A unique compound 3c targets GSK-3β and metal ion, interferes with tau and metal dyshomeostasis, promotes neurite outgrowth, decreases Aβ accumulation and ABTS•+, and enhances zebrafish motility
Bioorganic Chemistry · 2026-06 · 174 · 109760
DOI: 10.1016/j.bioorg.2026.109760 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-06. Verfasst von Jing Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China. Hauptthemen laut MEDLINE: Glycogen Synthase Kinase 3 beta, Amyloid beta-Peptides, tau Proteins, Sulfonic Acids. Die Arbeit nennt 66 Literaturangaben. Gefördert von: Shandong Province Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
As a progressive neurodegenerative condition, Alzheimer's disease (AD) can be caused by multiple pathological factors. In this study, we designed and synthesized three novel compounds targeting glycogen synthase kinase-3β (GSK-3β) and metal ion to interfere with the key pathological pathways involved in tau phosphorylation, metal dyshomeostasis, and amyloid-β (Aβ) accumulation. Notably, compound 3c demonstrated the greatest GSK-3β inhibitory effect (IC50 = 0.66 ± 0.19 nM) and favorable targeting specificity for GSK-3. 3c effectively inhibited GSK-3β activity possibly through enhancing the expression of p-GSK-3β-Ser9, thereby indirectly suppressing Aβ25-35-mediated tau-Ser396 phosphorylation. Additionally, 3c exhibited chelating effects toward pathogenic metal ions, effectively inhibited the accumulation of Cu2+-Aβ1-42 aggregates, and surprisingly, it directly targeted Aβ1-42. Moreover, 3c displayed additional anti-AD effects, including the upregulation of β-catenin and neurogenesis-associated biomarkers, the promotion of neurite outgrowth, and the scavenging of ABTS free radicals (ABTS•+). Notably, 3c obviously enhanced the motility of AD zebrafish and preliminarily demonstrated low toxicity. Together, we identified a distinct compound, 3c, with multiple anti-AD effects and potential as a drug candidate for further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.
- Department of Spinal Surgery, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China.
- Medical Research Center, Affiliated Hospital of Jining Medical University, Jining Medical University, Jining, Shandong, China. Electronic address: sxlmm0924@163.com.
Förderung
- Shandong Province Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Zhang, J., Li, Y., Li, Y. P., Xun, Q. Q., Ma, Y. Y., & Shi, X. L. (2026). A unique compound 3c targets GSK-3β and metal ion, interferes with tau and metal dyshomeostasis, promotes neurite outgrowth, decreases Aβ accumulation and ABTS•+, and enhances zebrafish motility. Bioorganic Chemistry, 174, 109760. https://doi.org/10.1016/j.bioorg.2026.109760
Vancouver
Zhang J, Li Y, Li YP, Xun QQ, Ma YY, Shi XL. A unique compound 3c targets GSK-3β and metal ion, interferes with tau and metal dyshomeostasis, promotes neurite outgrowth, decreases Aβ accumulation and ABTS•+, and enhances zebrafish motility. Bioorganic Chemistry. 2026;174:109760. doi:10.1016/j.bioorg.2026.109760
BibTeX
@article{Zhang2026,
author = {Zhang, Jing and Li, Ying and Li, Yan-Peng and Xun, Qing-Qing and Ma, Yu-Ying and Shi, Xiao-Long},
title = {A unique compound 3c targets GSK-3β and metal ion, interferes with tau and metal dyshomeostasis, promotes neurite outgrowth, decreases Aβ accumulation and ABTS•+, and enhances zebrafish motility},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {174},
pages = {109760},
doi = {10.1016/j.bioorg.2026.109760}
}
EUVIMED